Back
Sagimet Biosciences Stock Predictions
The Future of Housing Is Being Built Now
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.
Sell
49
SGMT
Sagimet Biosciences
Last Price:
$3.46
Seasonality Move:
-40.51%
7 Day Trial
ALL ACCESS PASS
$
7
Pacaso has reserved the Nasdaq ticker PCSO and is offering shares at just $2.80 - but only until May 29.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.*Pacaso recently received their ticker reservation with NasdaqSagimet Biosciences Stock Forecast
-
Is Sagimet Biosciences Stock Undervalued?The current Sagimet Biosciences [SGMT] share price is $3.45. The Score for SGMT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
SGMT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Sagimet Biosciences Stock Go Up Next Year?
Data Unavailable
Sagimet Biosciences Stock Rating
Data Unavailable
Sagimet Biosciences Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sagimet.com
52-Week Data
52-Week High:
7.38
52-Week Low:
1.73
Prediction Charts
Market Cap:
111.1M
Price in USD:
3.45
Volume:
117.5K
Beta:
2.41
Technical Analysis
SMA50:
3.13
SMA100:
3.71
SMA200:
4.00
52-Wk Change:
-26.6%
Stock Predictions
-
Is Sagimet Biosciences stock public?Yes, Sagimet Biosciences is a publicly traded company.
-
What is the Sagimet Biosciences stock quote today?The Sagimet Biosciences stock price is 3.45 USD today.
-
How to buy Sagimet Biosciences stock online?You can buy Sagimet Biosciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| May-6 | 3.50 | 3.27 | 3.50 | 3.24 |
| May-7 | 3.27 | 3.34 | 3.40 | 3.26 |
| May-8 | 3.45 | 3.20 | 3.45 | 3.19 |
| May-9 | 3.23 | 3.26 | 3.42 | 3.22 |
| May-12 | 3.36 | 3.31 | 3.48 | 3.27 |
| May-13 | 3.35 | 3.18 | 3.38 | 3.09 |
| May-14 | 3.10 | 3.10 | 3.24 | 3.09 |
| May-15 | 3.12 | 3.31 | 3.33 | 3.08 |
| May-16 | 3.30 | 3.22 | 3.37 | 3.19 |
| May-19 | 3.18 | 3.43 | 3.49 | 3.18 |
| May-20 | 3.43 | 3.43 | 3.50 | 3.32 |
| May-21 | 3.38 | 3.22 | 3.49 | 3.15 |
| May-22 | 3.22 | 3.41 | 3.47 | 3.15 |
| May-23 | 3.23 | 3.45 | 3.48 | 3.23 |
Sagimet Biosciences Earnings
Data Unavailable
Sagimet Biosciences Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.27 per share, a decrease this year of $0.76 per share, and a decrease next year of $0.39 per share.
* Sagimet Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.